EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?

Yoon Kong Loke iD, Katharina Mattishent iD, Navena Navaneetharaja

Pharmacy · 10.02.2024 · 12 (1) · 33

DOI: 10.3390/pharmacy12010033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacy, online erschienen am 10.02.2024. Verfasst von Yoon Kong Loke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spontaneous adverse events reporting systems are used internationally to flag new or unexpected adverse drug reactions (ADRs). Disproportionality analysis is a recognised technique, but false alarms may arise. We aimed to determine whether these new ADR signals had subsequently been followed-up with detailed hypothesis-testing studies. We searched PubMed to identify published studies (years 2017–2021) where the authors reported findings of new ADR signals from disproportionality analyses. We used PubMed and forward citation tracking (Google Scholar) to identify any subsequent confirmatory studies of these ADR signals. We screened 414 titles and abstracts and checked the full-text articles of 57 studies. We found signals for 56 suspected new ADRs from 24 drugs. Google Scholar showed that the ADR studies had been cited a median of seven times (range 0–61). However, none of the suspected new ADRs had undergone detailed evaluation in the citing literature. Similarly, our PubMed search did not find any confirmation studies for the 56 suspected new ADRs. Although many suspected new ADR signals have been identified through disproportionality analysis, most signals have not been further verified as being either genuine ADRs or false alarms. Researchers must focus on follow-up studies for these new signals.

Schlagwörter

Stichwörter der Autor:innen

adverse eventsdisproportionality analysispharmacovigilance

Autor:innen und Institutionen

  • Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.

ORCID-Profile: Yoon Kong Loke, Katharina Mattishent

Zitieren

APA

Loke, Y. K., Mattishent, K., & Navaneetharaja, N. (2024). New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?. Pharmacy, 12(1), 33. https://doi.org/10.3390/pharmacy12010033

Vancouver

Loke YK, Mattishent K, Navaneetharaja N. New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?. Pharmacy. 2024;12(1):33. doi:10.3390/pharmacy12010033

BibTeX
@article{Loke2024,
  author = {Loke, Yoon Kong and Mattishent, Katharina and Navaneetharaja, Navena},
  title = {New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?},
  journal = {Pharmacy},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {33},
  doi = {10.3390/pharmacy12010033}
}
Kostenlos starten →